NORETHINDRONE AND ETHINYL ESTRADIOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Norethindrone And Ethinyl Estradiol, and when can generic versions of Norethindrone And Ethinyl Estradiol launch?
Norethindrone And Ethinyl Estradiol is a drug marketed by Watson Labs, Watson Pharms Teva, Dr Reddys Labs Sa, Mylan Labs Ltd, Naari Pte Ltd, Watson Labs Teva, Apil, Amneal Pharms, Barr, and Lupin Ltd. and is included in twenty-four NDAs.
The generic ingredient in NORETHINDRONE AND ETHINYL ESTRADIOL is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for NORETHINDRONE AND ETHINYL ESTRADIOL
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 24 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 7 |
| Clinical Trials: | 41 |
| Patent Applications: | 166 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | NORETHINDRONE AND ETHINYL ESTRADIOL at DailyMed |
Recent Clinical Trials for NORETHINDRONE AND ETHINYL ESTRADIOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Virginia | Early Phase 1 |
| Achillion, a wholly owned subsidiary of Alexion | Phase 1 |
| Alexion Pharmaceuticals | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for NORETHINDRONE AND ETHINYL ESTRADIOL
US Patents and Regulatory Information for NORETHINDRONE AND ETHINYL ESTRADIOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | NORETHINDRONE AND ETHINYL ESTRADIOL | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 078379-001 | Feb 23, 2010 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Apil | NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | ethinyl estradiol; norethindrone | TABLET, CHEWABLE;ORAL | 022573-001 | Dec 22, 2010 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Naari Pte Ltd | NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | ethinyl estradiol; norethindrone | TABLET;ORAL | 207066-001 | Mar 29, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
